INMED PHARMACEUTICALS INC (INM) Stock Income Statement
NASDAQ:INM • CA4576377002
0.91 USD
-0.02 (-2.15%)
Last: Mar 5, 2026, 01:04 PM
| TTM (2025-9-30) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.80M | 4.94M | 4.60M | 4.14M | 1.09M | |||
| Cost Of Goods | 3.18M | 3.24M | 3.50M | 2.73M | 550.00K | |||
| Gross Profit | 1.62M | 1.71M | 1.10M | 1.40M | 540.00K | |||
| Operating Expenses | 9.54M | 9.62M | 9.24M | 9.78M | 14.13M | |||
| Research and Development | 2.57M | 2.90M | 3.77M | 3.73M | 7.28M | |||
| Selling, General, and Administrative Expenses | 6.66M | 6.51M | 5.25M | 5.85M | 6.67M | |||
| Operating Income | -7.93M | -7.92M | -8.13M | -8.38M | -13.59M | |||
| Interest Income/Expense | -283.80K | -244.10K | 466.00K | 440.00K | -20.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -1.31M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | -3.67M | |||
| Income Before Taxes | -8.21M | -8.16M | -7.67M | -7.93M | -18.60M | |||
| Income Tax | 0.00 | 0.00 | 7.10K | 10.00K | N/A | |||
| Net Income | -8.21M | -8.16M | -7.68M | -7.95M | -18.60M | |||
| EBITDA | -7.72M | -7.71M | -7.91M | -8.18M | -13.40M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -7.21 | -8.36 | -20.14 | -3.25 | -33.21 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -685.60 | |||
| Statistics | ||||||||
| Gross Profit Margin | 33.69% | 34.53% | 23.94% | 33.82% | 49.54% | |||
| Profit Margin | -171.13% | -165.14% | -166.94% | -192.03% | -1706.42% | |||
| Operating Profit Margin | -165.22% | -160.20% | -176.92% | -202.42% | -1246.79% | |||
All data in USD